Seagen (Seattle Genetics)
Venture Capital
American oncology biotech company (formerly Seattle Genetics) focused on antibody-drug conjugates; acquired by Pfizer for $43B in December 2023.
Bothell, United States · 1+ investments
Biotech
Oncology
- Headquarters
- Bothell, United States
- Founded
- 1997
- Website
- seagen.com
- Total Investment
- 1
- Last Investment
- Jan 2018
- Geographic Focus
- United States
Overview
Seagen (Seattle Genetics) is a Venture Capital firm based in Bothell, United States. It has made 1 investment in Biotech and Oncology.
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.